| Dr Jodi D Kaufman, MD | |
|
147 E 3rd St, Suite One, Moorestown, NJ 08057-2924 | |
| (856) 234-7754 | |
| (856) 234-2290 |
| Full Name | Dr Jodi D Kaufman |
|---|---|
| Gender | Female |
| Speciality | Internal Medicine |
| Experience | 37 Years |
| Location | 147 E 3rd St, Moorestown, New Jersey |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1265403935 | NPI | - | NPPES |
| 5178401 | Medicaid | NJ | |
| 1039728 | Other | NJ | HORIZON NJ HEALTH |
| 000619079 | Other | NJ | IND BC PPO |
| 0448369000 | Other | NJ | AMERIHEALTH/KHPE/IND BCBS |
| 0500085001 | Other | NJ | AMERIHEALTH KHPE IND BC |
| 3126555 | Other | NJ | CIGNA |
| OK2157 | Other | NJ | PHS |
| 5178401 | Other | NJ | UNISYS |
| 110046661 | Other | NJ | RAILROAD MEDICARE |
| 4662898 | Other | NJ | AETNA |
| P395156 | Other | NJ | OXFORD |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | MA56789 (New Jersey) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Bayada Home Health Care, Inc | Cherry hill, NJ | Home health agency |
| Moorestown Visiting Nurse Association | Moorestown, NJ | Home health agency |
| Virtua Home Care At West Jersey | Mount laurel, NJ | Home health agency |
| Virtua Memorial Hospital Of Burlington County | Mount holly, NJ | Hospital |
| Virtua West Jersey Hospitals | Voorhees, NJ | Hospital |
| Penn Presbyterian Medical Center | Philadelphia, PA | Hospital |
| Virtua Our Lady Of Lourdes Hospital | Camden, NJ | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Virtua Medical Group, Pa | 9830222397 | 1226 |
News Archive
VIVUS, Inc. today announced that the U.S. Food and Drug Administration (FDA) has accepted for filing and review the New Drug Application (NDA) for Qnexa to treat obesity. The company resubmitted the NDA on October 17, 2011.
Malaria is a life-threatening condition that exposes approximately half of the world's population to the risk of developing a severe and often lethal form of disease. In a study published in the latest issue of the journal Cell Host & Microbe*, Miguel Soares and his team at Instituto Gulbenkian de Ci-ncia (IGC), Portugal, discovered that the development of severe forms of malaria can be prevented by a simple mechanism that controls the accumulation of iron in tissues of the infected host.
Autonomic Technologies, Inc. (ATI), the developer of a novel miniaturized implantable system for severe headaches, today announced positive preliminary findings from a study evaluating the safety and efficacy of the company's investigational neurostimulation system for the treatment of cluster headache.
The bacteria that caused the Black Death or plague, which wiped out millions in mid-14th century Europe, may be extinct, according to a new study. The Black Death claimed the lives of one-third of Europeans in just five years from 1348 to 1353. Until recently, it was not certain whether the bacterium Yersinia pestis - known to cause the plague today - was responsible for that most deadly outbreak of disease ever. Now, the University of Tübingen's Institute of Scientific Archaeology and McMaster University in Canada have been able to confirm that Yersinia pestis was behind the great plague.
Aditlys is the first medical technology firm to develop a bioresorbable vascular access solution for patients undergoing dialysis treatment for chronic kidney disease. Aditlys' polymer-based graft enables a patient's body to naturally reconstruct its own blood vessels using the body's own tissue.
› Verified 3 days ago
| Entity Name | Virtua Medical Group, Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1649226515 PECOS PAC ID: 9830222397 Enrollment ID: O20100804000338 |
News Archive
VIVUS, Inc. today announced that the U.S. Food and Drug Administration (FDA) has accepted for filing and review the New Drug Application (NDA) for Qnexa to treat obesity. The company resubmitted the NDA on October 17, 2011.
Malaria is a life-threatening condition that exposes approximately half of the world's population to the risk of developing a severe and often lethal form of disease. In a study published in the latest issue of the journal Cell Host & Microbe*, Miguel Soares and his team at Instituto Gulbenkian de Ci-ncia (IGC), Portugal, discovered that the development of severe forms of malaria can be prevented by a simple mechanism that controls the accumulation of iron in tissues of the infected host.
Autonomic Technologies, Inc. (ATI), the developer of a novel miniaturized implantable system for severe headaches, today announced positive preliminary findings from a study evaluating the safety and efficacy of the company's investigational neurostimulation system for the treatment of cluster headache.
The bacteria that caused the Black Death or plague, which wiped out millions in mid-14th century Europe, may be extinct, according to a new study. The Black Death claimed the lives of one-third of Europeans in just five years from 1348 to 1353. Until recently, it was not certain whether the bacterium Yersinia pestis - known to cause the plague today - was responsible for that most deadly outbreak of disease ever. Now, the University of Tübingen's Institute of Scientific Archaeology and McMaster University in Canada have been able to confirm that Yersinia pestis was behind the great plague.
Aditlys is the first medical technology firm to develop a bioresorbable vascular access solution for patients undergoing dialysis treatment for chronic kidney disease. Aditlys' polymer-based graft enables a patient's body to naturally reconstruct its own blood vessels using the body's own tissue.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Jodi D Kaufman, MD 301 Lippincott Dr Ste 410, Marlton, NJ 08053-4197 Ph: (856) 355-0340 | Dr Jodi D Kaufman, MD 147 E 3rd St, Suite One, Moorestown, NJ 08057-2924 Ph: (856) 234-7754 |
News Archive
VIVUS, Inc. today announced that the U.S. Food and Drug Administration (FDA) has accepted for filing and review the New Drug Application (NDA) for Qnexa to treat obesity. The company resubmitted the NDA on October 17, 2011.
Malaria is a life-threatening condition that exposes approximately half of the world's population to the risk of developing a severe and often lethal form of disease. In a study published in the latest issue of the journal Cell Host & Microbe*, Miguel Soares and his team at Instituto Gulbenkian de Ci-ncia (IGC), Portugal, discovered that the development of severe forms of malaria can be prevented by a simple mechanism that controls the accumulation of iron in tissues of the infected host.
Autonomic Technologies, Inc. (ATI), the developer of a novel miniaturized implantable system for severe headaches, today announced positive preliminary findings from a study evaluating the safety and efficacy of the company's investigational neurostimulation system for the treatment of cluster headache.
The bacteria that caused the Black Death or plague, which wiped out millions in mid-14th century Europe, may be extinct, according to a new study. The Black Death claimed the lives of one-third of Europeans in just five years from 1348 to 1353. Until recently, it was not certain whether the bacterium Yersinia pestis - known to cause the plague today - was responsible for that most deadly outbreak of disease ever. Now, the University of Tübingen's Institute of Scientific Archaeology and McMaster University in Canada have been able to confirm that Yersinia pestis was behind the great plague.
Aditlys is the first medical technology firm to develop a bioresorbable vascular access solution for patients undergoing dialysis treatment for chronic kidney disease. Aditlys' polymer-based graft enables a patient's body to naturally reconstruct its own blood vessels using the body's own tissue.
› Verified 3 days ago
Dr. Vincent William Savarese, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 703 E Main St, Moorestown, NJ 08057 Phone: 856-727-0900 | |
James W Lee, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 350 Young Ave Ste 200, Moorestown, NJ 08057 Phone: 609-702-1900 Fax: 609-702-8456 | |
Dr. Morton Hoffman, MD Internal Medicine Medicare: Medicare Enrolled Practice Location: 5 Shelter Rock Place, Moorestown, NJ 08057 Phone: 856-234-1406 Fax: 856-234-0918 | |
Dr. Samuel M Ventrella, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 728 Marne Hwy Ste 200a, Moorestown, NJ 08057 Phone: 856-291-8855 Fax: 856-291-8844 | |
Maurice J Cairoli, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 350 Young Ave Ste 200, Moorestown, NJ 08057 Phone: 609-702-1900 Fax: 609-702-8456 | |
Stephen G Wallace, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 350 Young Ave Ste 200, Moorestown, NJ 08057 Phone: 609-702-1900 Fax: 609-702-8455 | |
Dr. Eduard Koman, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 728 Marne Hwy Ste 200a, Moorestown, NJ 08057 Phone: 856-291-8855 Fax: 856-291-8844 |